Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Modified stem cells offer potential pathway to treat Alzheimer's disease

  • Scientists explain how memories stick together

  • In old age, lack of emotion, interest may signal brain is shrinking

  • Book early, after work if you want to enjoy your next hotel stay

  • Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

  • Distracted driving among teens threatens public health and safety

  • Conceptual representation in the brain: Towards mind-reading?

  • Common links between neurodegenerative diseases identified

  • For resetting circadian rhythms, neural cooperation is key

  • Neurons in brain tune into different frequencies for different spatial memory tasks

  •